University Animal Care Committee Standard Operating Procedure
Document No: 7.1
Subject: Pain Management in Mice
Date Issued: February 16, 2012
Location: Queen’s University
Responsibility: Principal Investigators, Research Staff, Veterinary Staff
Purpose: The purpose of this Standard Operating Procedure (SOP) is to describe methods for assessing and treating pain in rodents.
1. Introduction and Definitions:
- Based on the definition of pain from the American College of Laboratory Animal Medicine (ACLAM), pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage and should be expected in an animal subjected to any procedure or disease model that would be likely to cause pain in a human.
- It is generally agreed that pain adversely impacts the welfare of animals and that in research protocols, pain, if not controlled, is a variable which can confound the interpretation of experimental results.
- Procedures expected to cause more than slight or momentary pain (e.g., pain in excess of a needle poke or injection) require the appropriate use of pain-relieving measures unless scientifically justified in an approved animal use protocol (AUP).
- Pain management is an important ethical and moral issue but is challenged by inconsistency related to lack of evidence based effective doses for different strains, the challenge of assessing pain and the ability to reduce pain. This results in extrapolation from other species to rodents for dose rates.
- The following tables provide some options for general analgesics and local analgesics that can be used. Multi-modal pain management is utilized frequently as well as regional analgesia.
Animal Care Services ACS, Principal Investigator PI, subcutaneous SC, intravenous IV, intraperitoneal IP, intramuscular IM, per os PO, per rectum PR
- Clinical Assessment of Post-Procedural Pain
- The most reliable signs of pain and distress in rodents are changes in behaviour, thus it is important that the animal user has a good knowledge of species specific and individual behaviour. The animal user should also be aware of any strain differences that could affect the animal’s response to pain and or the medications used to treat said pain.
- All animals should be observed initially from a distance, so their natural behaviour is not inhibited. This should be followed by a closer examination. The use of additional aides to interpret the presence of pain can also be utilized eg) the Grimace scale.
- Frequency of observation should be procedure specific, but not less than once per day.
- Contact veterinary staff if any changes in animal behaviour are observed.
- Common clinical signs of pain and distress include:
- Reduced grooming
- Reduced level of spontaneous activity
- Rough hair coat
- Hunched posture
- Increased aggression when handled.
- Isolation/separation from cage mates
- Reduced food/water intake
- Pale extremities
- Sunken eyes/dehydration
- Squinty eyes
- Wound licking
- Orbital tightening
- Abnormal gait
- Vocalization when handled
- Management of Pain
- Non-pharmacological considerations:
- Providing appropriate housing, handling and restraint as well as using appropriate experimental techniques can support pain management.
- Fluid and heat therapy are generally provided for rodents displaying signs of pain.
- Easy access to moist chow or lab-diet gel. Lab diet gel must be replaced daily.
- Pharmacological considerations:
- If not contraindicated by the experimental protocol, preemptive, multi-modal analgesia should be used. For example, administration of a combination including an opioid, non-steroidal anti- inflammatory (NSAID) and a local analgesic.
- Local Anesthetics:
- Local anesthetic should be infiltrated at the site where the painful stimulus will be induced:
- Non-pharmacological considerations:
|Lidocaine||< 2 mg/kg||30 – 60 minutes||
|Bupivacaine||< 2 mg/kg||4 – 7 hrs.||
As above with the exception:
|Lidocaine/bupivacaine||-||Up to 7 hrs.||
|Acetaminophen||100 – 300 mg/kg||PO||q 4 hr.|
|Meloxicam (Long Term)||1 – 6 mg/kg||SC, PO||q 12-24 hr.|
|Meloxicam (Post-surgical – 3 days)||10 mg/kg||SC, PO||q 12-24 hr.|
|Ketoprofen||5 mg/kg||SC||q 12-24 hr.|
|Carprofen||2.5- 5 mg/kg||SC, IP||q 24 hr.|
|Tramadol||20 – 40 mg/kg||SC, IP||q 24 hr.|
|Buprenorphine||0.05 – 0.1 mg/kg||SC, IP||q 6 – 12 hr.|
|Buprenorphine SR||0.1 mg/kg||SC, IP||q 48 hr.|
- Fish RE, Brown MJ, Danneman PJ, Karas AZ. Ed. (2008) Anesthesia and Analgesia in Laboratory Animals 2nd Ed. Academic Press, New York
- University of Michigan-Guidelines on Anesthesia and Analgesia in Mice –Approved May 19, 2023
- Clinical Management of Pain in Rodents-Comparative Medicine Vol 69, No December 2019, pages 468-489
- High-dose Meloxicam Provides Improved Analgesia in Female CD1 mice: A Pharmacokinetic and efficacy Study JAALAS Volume 62, NO 1, January 2023, pages 74-80, J. Kim, BA Cannon, LE Freeman et al
- Review of Long-Acting Parenteral Analgesics for Mice and Rats Vol 61, Number 6, November 2022 pages 595-602 M.K. Huss, C. Pacharinsak
|10/17/2023||Drug dose update, format change|